P. Gallo

发表

Adenovirus as vehicle for anticancer genetic immunotherapy

P. Monaci, S. Dharmapuri, P. Gallo, 2005, Gene Therapy.

Class A helix-loop-helix proteins are positive regulators of several cyclin-dependent kinase inhibitors' promoter activity and negatively affect cell growth.

L. Lania, A. Pagliuca, P. De Luca, 2000, Cancer research.

Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector

P. Monaci, P. Musiani, G. Forni, 2005, International journal of cancer.

Adenovirus vaccination against neu oncogene exerts long‐term protection from tumorigenesis in BALB/neuT transgenic mice

P. Monaci, G. Forni, S. Dharmapuri, 2007, International Journal of Cancer.

Small Interfering RNA-Induced Transcriptional Gene Silencing in Human Cells

L. Lania, A. Pagliuca, P. D. Luca, 2004 .

Differential role for Sp1/Sp3 transcription factors in the regulation of the promoter activity of multiple cyclin‐dependent kinase inhibitor genes

L. Lania, A. Pagliuca, P. Gallo, 2000, Journal of cellular biochemistry.

The CDK9-associated cyclins T1 and T2 exert opposite effects on HIV-1 Tat activity.

A. Giordano, L. Lania, B. Majello, 1999, AIDS.

Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors.

P. Monaci, M. Kraus, G. Forni, 2007, International journal of oncology.